S&P 500   3,265.48 (+0.58%)
DOW   26,909.21 (+0.35%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.78 (-0.72%)
CGC   13.92 (-2.45%)
GE   6.04 (-0.33%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.83 (-0.75%)
F   6.53 (-1.95%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.35 (+0.69%)
DIS   122.45 (-0.03%)
BAC   23.28 (-0.26%)
BA   150.58 (+3.10%)
S&P 500   3,265.48 (+0.58%)
DOW   26,909.21 (+0.35%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.78 (-0.72%)
CGC   13.92 (-2.45%)
GE   6.04 (-0.33%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.83 (-0.75%)
F   6.53 (-1.95%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.35 (+0.69%)
DIS   122.45 (-0.03%)
BAC   23.28 (-0.26%)
BA   150.58 (+3.10%)
S&P 500   3,265.48 (+0.58%)
DOW   26,909.21 (+0.35%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.78 (-0.72%)
CGC   13.92 (-2.45%)
GE   6.04 (-0.33%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.83 (-0.75%)
F   6.53 (-1.95%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.35 (+0.69%)
DIS   122.45 (-0.03%)
BAC   23.28 (-0.26%)
BA   150.58 (+3.10%)
S&P 500   3,265.48 (+0.58%)
DOW   26,909.21 (+0.35%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.78 (-0.72%)
CGC   13.92 (-2.45%)
GE   6.04 (-0.33%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.83 (-0.75%)
F   6.53 (-1.95%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.35 (+0.69%)
DIS   122.45 (-0.03%)
BAC   23.28 (-0.26%)
BA   150.58 (+3.10%)
Log in
NASDAQ:GOED

Inozyme Pharma Stock Forecast, Price & News

$7.00
+0.20 (+2.94 %)
(As of 09/25/2020 12:23 PM ET)
Add
Compare
Today's Range
$7.00
Now: $7.00
$7.00
50-Day Range N/A
52-Week Range
$5.65
Now: $7.00
$10.50
Volume60 shs
Average Volume21,749 shs
Market Capitalization$42.78 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
1847 Goedeker Inc. operates as an online marketplace for home furnishings products. It sells home appliances, including refrigerators, ranges, ovens, dishwashers, microwaves, freezers, washers, and dryers; furniture; and other products in the décor, bed and bath, lighting, outdoor living, and electronics categories. The company was founded in 1951 and is headquartered in Ballwin, Missouri. 1847 Goedeker Inc. is a subsidiary of 1847 Goedeker Holdco Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Internet Retail
Sub-IndustryN/A
Current SymbolNASDAQ:GOED
CUSIPN/A
CIKN/A
Phone888 768 1710

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees67
Market Cap$42.78 million
Next Earnings Date11/19/2020 (Estimated)
OptionableNot Optionable
$7.00
+0.20 (+2.94 %)
(As of 09/25/2020 12:23 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GOED News and Ratings via Email

Sign-up to receive the latest news and ratings for GOED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Inozyme Pharma (NASDAQ:GOED) Frequently Asked Questions

When is Inozyme Pharma's next earnings date?

Inozyme Pharma is scheduled to release its next quarterly earnings announcement on Thursday, November 19th 2020.
View our earnings forecast for Inozyme Pharma
.

Who are some of Inozyme Pharma's key competitors?

What other stocks do shareholders of Inozyme Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inozyme Pharma investors own include Adobe (ADBE), Oroplata Resources (ABML), Bellus Health (BLU), Capricor Therapeutics (CAPR), Ciena (CIEN), Editas Medicine (EDIT), Eros International (EROS), ETHEREUM CLASSI/SHS (ETCG), Freeport-McMoRan (FCX) and Franco Nevada (FNV).

Who are Inozyme Pharma's key executives?

Inozyme Pharma's management team includes the following people:
  • Mr. Douglas T. Moore, CEO & Director (Age 63)
  • Mr. Robert D. Barry CPA, Chief Financial Officer (Age 76)

When did Inozyme Pharma IPO?

(GOED) raised $10 million in an initial public offering on Friday, July 31st 2020. The company issued 1,000,000 shares at $9.00-$11.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO and Aegis Capital and Spartan Capital Securities were co-managers.

What is Inozyme Pharma's stock symbol?

Inozyme Pharma trades on the NASDAQ under the ticker symbol "GOED."

When did Inozyme Pharma's quiet period expire?

Inozyme Pharma's quiet period expired on Wednesday, September 9th. Inozyme Pharma had issued 1,111,200 shares in its initial public offering on July 31st. The total size of the offering was $10,000,800 based on an initial share price of $9.00. During Inozyme Pharma's quiet period, insiders and any underwriters that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Inozyme Pharma?

Shares of GOED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inozyme Pharma's stock price today?

One share of GOED stock can currently be purchased for approximately $7.00.

How big of a company is Inozyme Pharma?

Inozyme Pharma has a market capitalization of $42.78 million. Inozyme Pharma employs 67 workers across the globe.

What is Inozyme Pharma's official website?

The official website for Inozyme Pharma is www.goedekers.com.

How can I contact Inozyme Pharma?

The company can be reached via phone at 888 768 1710.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.